Enovix is trading at $2.80, up 13.82% in pre-market on October 12, compared with the October 9 close of $2.46.
- No verified company announcement or major event has been identified as a catalyst.
- Wall Street Zen’s rating change from “strong sell” to “sell” was reported, but available coverage does not establish it explains the move.
- Broader market indicators are mixed, offering no clear market-wide explanation.